SAM
AVNS

Shamrock Asset Management’s Avanos Medical AVNS Stock Holding History

Shamrock Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-75
Closed -$3.37K – 266
2015
Q1 		$4K Buy
+75
New +$3.47K ﹤0.01% 255

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Shamrock Asset Management's AVNS Position: Q2 2015 in Review

Shamrock Asset Management sold out of Avanos Medical (AVNS) in Q2 2015, closing a stake of 75 shares — an estimated $3.37K sold.

Shamrock Asset Management first reported a position in AVNS in Q1 2015 and held it in 1 quarter. The position peaked at $4K in Q1 2015. 419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

  • Shamrock Asset Management reported no remaining Avanos Medical position as of Q2 2015 after selling out during the quarter.
  • Shamrock Asset Management sold 75 Avanos Medical shares in Q2 2015, an estimated $3.37K.
  • Shamrock Asset Management first reported a position in Avanos Medical in Q1 2015 and held it in 1 quarter.
  • Shamrock Asset Management's Avanos Medical position peaked at $4K in Q1 2015.
  • 419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on Shamrock Asset Management's 13F filing for Q2 2015, filed 10 Aug 2015.